Please enter a valid month/year e.g. 01/2015

Pick a date between March 2000 and November 2022

Showing 1 to 8 of 8
Title Type Anticipated publication date
Afamelanotide for treating erythropoietic protoporphyria [ID927] Highly specialised technology Anticipated publication date:23 May 2018 20180523
Cerliponase alfa for treating neuronal ceroid lipofuscinosis type 2 [ID943] Highly specialised technology Anticipated publication date:27 June 2018 20180627
Drisapersen for the first-line treatment of Duchenne’s muscular dystrophy [ID911] Highly specialised technology Anticipated publication date:TBC 0
Eteplirsen for treating Duchenne muscular dystrophy [ID1003] Highly specialised technology Anticipated publication date:24 October 2018 20181024
Lysosomal acid lipase deficiency - sebelipase alfa [ID737] Highly specialised technology Anticipated publication date:TBC 0
Metreleptin for treating lipodystrophy (ID861) Highly specialised technology Anticipated publication date:26 September 2018 20180926
Strimvelis for treating severe combined immunodeficiency caused by adenosine deaminase deficiency [ID926] Highly specialised technology Anticipated publication date:28 February 2018 20180228
Velmanase alfa for treating alpha-mannosidosis [ID800] Highly specialised technology Anticipated publication date:26 September 2018 20180926